DrugPatentWatch Database Preview
DOXYCYCLINE HYCLATE - Generic Drug Details
What are the generic drug sources for doxycycline hyclate and what is the scope of doxycycline hyclate freedom to operate?
Doxycycline hyclate
is the generic ingredient in fifteen branded drugs marketed by Pliva, Mayne Pharma Intl, Warner Chilcott, Medicis, Aqua Pharms, Teva, Actavis Labs Fl Inc, Ajanta Pharma Ltd, Alembic Pharms Ltd, Amneal Pharms, Chartwell Life Sci, Halsey, Heather, Hikma Intl Pharms, Interpharm, Mutual Pharm, Mylan, Par Pharm, Pvt Form, Ranbaxy, Sun Pharm Industries, Superpharm, Watson Labs, Zydus Pharms Usa Inc, Collagenex, Pfizer, Fresenius Kabi Usa, Rachelle, Mylan Labs Ltd, West-ward Pharms Int, Tolmar, Mayne Pharma, Actavis Elizabeth, Heritage Pharms Inc, Impax Labs Inc, Mylan Pharms Inc, Prinston Inc, Aqua Pharms Llc, Amneal Pharms Co, Caribe Holdings, Emcure Pharms Ltd, Epic Pharma Llc, Ivax Sub Teva Pharms, Lannett Co Inc, Larken Labs, Lupin Ltd, Mayne Pharma Inc, Novel Labs Inc, Vintage Pharms, Chartwell Pharma, and Galderma Labs Lp, and is included in seventy-five NDAs. There are five patents protecting this compound and seven Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.Doxycycline hyclate has two patent family members in two countries.
There are twenty-eight drug master file entries for doxycycline hyclate. Ninety-seven suppliers are listed for this compound.
Summary for DOXYCYCLINE HYCLATE
| International Patents: | 2 |
| US Patents: | 5 |
| Tradenames: | 15 |
| Applicants: | 51 |
| NDAs: | 75 |
| Drug Master File Entries: | 28 |
| Suppliers / Packagers: | 97 |
| Bulk Api Vendors: | 116 |
| Clinical Trials: | 8 |
| Patent Applications: | 3,129 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for DOXYCYCLINE HYCLATE |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for DOXYCYCLINE HYCLATE |
| DailyMed Link: | DOXYCYCLINE HYCLATE at DailyMed |
Pharmacology for DOXYCYCLINE HYCLATE
| Ingredient-type | Tetracyclines |
| Drug Class | Tetracycline-class Drug |
Synonyms for DOXYCYCLINE HYCLATE
| (1S,4aS,11R,11aR,12S,12aR)-3-carbamoyl-2,4a,5,7,12-pentahydroxy-N,N,11-trimethyl-4,6-dioxo-1,4,4a,6,11,11a,12,12a-octahydrotetracen-1-aminium chloride--ethanol--water (2/1/1) |
| (2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione |
| (2E,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; ethanol; hydrate; dihydrochloride |
| (2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; ethanol; hydrate; dihydrochloride |
| (2Z,4S,4AR,5S,5AR,6R,12AS)-2-[AMINO(HYDROXY)METHYLIDENE]-4-(DIMETHYLAMINO)-5,10,11,12A-TETRAHYDROXY-6-METHYL-1,2,3,4,4A,5,5A,6,12,12A-DECAHYDROTETRACENE-1,3,12-TRIONE |
| (2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione |
| (2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione hydrochloride |
| (2Z,4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione; ethanol; hydrate; dihydrochloride |
| (2Z,4S,4aR,5S,5aR,6R)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione |
| (2Z)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione |
| (4S,4aR,5S,5aR,6R,12aR)-4-(dimethylamino)-1,5,10,11,12a-pentahydroxy-6-methyl-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide |
| (4S,4aR,5S,5aR,6R,12aS)-2-[amino(hydroxy)methylidene]-4-(dimethylamino)-5,10,11,12a-tetrahydroxy-6-methyl-4a,5,5a,6-tetrahydro-4H-tetracene-1,3,12-trione |
| (4S,4aR,5S,5aR,6R,12aS)-4-(Dimethylamino)- 3,5,10,12,12a-pentahydroxy- 6-methyl- 1,11-dioxo- 1,4,4a,5,5a,6,11,12a-octahydrotetracene- 2-carboxamide hydrochloride hemiethanolate hemihydrate |
| (4s,4ar,5s,5ar,6r,12as)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide |
| (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide |
| (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide - ethanol (2:1) dihydrochloride hydrate |
| (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide compound with ethanol (2:1) dihydrochloride hydrate |
| (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide |
| (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide;ethanol;hydrate;dihydrochloride |
| 100929-47-3 |
| 10592-13-9 |
| 10592-13-9 (. HCl) |
| 10597-92-9 |
| 1368-EP2269978A2 |
| 1368-EP2269985A2 |
| 1368-EP2269991A2 |
| 1368-EP2284150A2 |
| 1368-EP2284151A2 |
| 1368-EP2284152A2 |
| 1368-EP2284153A2 |
| 1368-EP2284155A2 |
| 1368-EP2284156A2 |
| 1368-EP2284164A2 |
| 1368-EP2287140A2 |
| 1368-EP2287148A2 |
| 1368-EP2287150A2 |
| 1368-EP2289871A1 |
| 1368-EP2295402A2 |
| 1368-EP2295419A2 |
| 1368-EP2298732A1 |
| 1368-EP2301534A1 |
| 1368-EP2301912A2 |
| 1368-EP2301913A1 |
| 1368-EP2301914A1 |
| 1368-EP2301916A2 |
| 1368-EP2305637A2 |
| 1368-EP2305640A2 |
| 1368-EP2308863A1 |
| 1368-EP2311451A1 |
| 1368-EP2311796A1 |
| 1368-EP2311797A1 |
| 1368-EP2311798A1 |
| 1368-EP2311799A1 |
| 1368-EP2316450A1 |
| 17086-28-1 (mono-hydrate) |
| 19XTS3T51U |
| 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a, 5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy -6-methyl-1,11-dioxo-, monohydrochloride, (4S,4aR,5S,5aR,6R,12aS)-, compd. with ethanol (2:1), mono |
| 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))- |
| 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS) |
| 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, (4S,4aR,5S,5aR,6R,12aS)- |
| 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, hydrochloride, (4S,4aR,5S,5aR,6R,12aS)-, compd. with ethanol, hydrate (2:2:1:1) |
| 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha,12aalpha))- |
| 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S,4aR,5S,5aR,6R,12aS)- |
| 2-Naphthacenecarboxamide, 4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, compd. with ethanol (2:1), monohydrate, (4S-(4alpha,4aalpha,5alpha,5aalpha,6alpha, |
| 2-Naphthacenecarboxamide, 4-alpha-S-(dimethylamino)-1,4,4a-alpha-5,5a-alpha,6,11,12a-octahydro-3,5-alpha,10,12,12a-alpha-pentahydroxy-6-alpha-methyl-1,11-dioxo- |
| 2-Naphthacenecarboxamide, 4-dimethylamino-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, hydrochloride |
| 2-Naphthacenecarboxamide, 4beta-(dimeethylamino)-1,4,4abeta,5,5abeta,6,11,12a-octahydro-3,5beta,10,12,12abeta-pentahydroxy-6beta-methyl-1,11-dioxo-, monohydrochloride, compd. with ethyl alcohol (2:1), monohydrate |
| 2-Naphthacenecarboxamide,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-, monohydrochloride, (4S,4aR,5S,5aR,6R,12aS)-, compd. with ethanol (2:1), monohydrate (9CI) (CA INDEX NAME) |
| 2387AH |
| 24390-14-5 |
| 2C22H24N2O8.C2H6O.2ClH.H2O |
| 2C22H24N2O8.C2H6O.H2O |
| 334895S862 |
| 390D145 |
| 4-(Dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride, compound with ethyl alcohol (2:1), monohydrate |
| 4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide - ethanol (2:1) dihydrochloride hydrate |
| 4-Epioxytetracycline, 6-deoxy- |
| 41411-66-9 (6-epimer, mono-hydrochloride) |
| 4182Z6T2ET |
| 5-Hydroxy-alpha-6-deoxytetracycline |
| 5-Hydroxy-alpha-6-deoxytetracycline monohydrate |
| 53108-42-2 |
| 564-25-0 |
| 564D250 |
| 6-alpha-Deoxy-5-oxytetracycline |
| 6-Deoxy-5-hydroxytetracycline hydrochloride hemihydrate |
| 6-Deoxyoxytetracycline |
| 6-Deoxytetracycline |
| 6-Desoxy-5-hydroxytetracycline hydrochloride hemihydrate hemiethanolate |
| 61281-03-6 |
| 62149-53-5 |
| 69935-17-7 (mono-hydrochloride, di-hydrate) |
| 6alpha-Deoxy-5-oxytetracycline |
| 7164-70-7 |
| 7264-10-0 |
| 94088-85-4 (calcium salt (1:2)) |
| AB00053465_04 |
| AB00053465_05 |
| AB00053465-03 |
| AB08 (*Fosfatex) |
| AC-12044 |
| AC-6017 |
| AC1L1WYQ |
| AC1NQXW7 |
| AC1NQZPV |
| AC1NTTH2 |
| AC1NUYS5 |
| AC1NUYS8 |
| Acticlate |
| Acticlate CAP |
| AK321970 |
| AK322076 |
| AKOS015900372 |
| AKOS015924649 |
| AKOS025310153 |
| AKOS025402170 |
| alpha-6-Deoxy-5-hydroxytetracycline |
| alpha-6-Deoxyoxytetracycline |
| alpha-6-Deoxyoxytetracycline monohydrate |
| alpha-6-Tetracycline monohydrate |
| alpha-Doxycycline |
| Alti-Doxycycline |
| Ambap100929-47-3 |
| AN-18097 |
| Anhydrous doxycycline |
| API0002491 |
| API0002492 |
| Apo-Doxy |
| AS-13499 |
| Atridox |
| Azudoxat |
| BCBcMAP01_000024 |
| Biocamycin |
| bis((4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide) ethanol hydrate dihydrochloride |
| BMY 28689 |
| BMY-28689 |
| BMY28689 |
| BSPBio_001936 |
| BU 3839T |
| BU-3839T |
| C-0055 |
| C06973 |
| C22H24N2O8.HCl.0.5H2O.0.5C2H6O |
| C22H25ClN2O8 |
| CAS-10592-13-9 |
| CCG-204498 |
| CCG-38949 |
| CHEBI:34730 |
| CHEBI:50845 |
| CHEBI:652992 |
| CHEMBL1200567 |
| CHEMBL1256723 |
| CHEMBL1433 |
| CHEMBL436921 |
| CS-2632 |
| D 9891 |
| D02129 |
| D07876 |
| D07877 |
| D0S0LZ |
| D4116 |
| DB00254 |
| Dentista |
| Deoxy-5-hydroxytetracycline hydrochloride |
| Deoxymykoin |
| Deoxyoxytetracycline hydrochloride |
| DivK1c_000345 |
| DMSC (*Fosfatex) |
| Doryx |
| Doryx (TN) |
| Doryx Mpc |
| Dossiciclina |
| Dossiciclina [DCIT] |
| DOXCYCLINE ANHYDROUS |
| Doxiciclina |
| Doxiciclina [INN-Spanish] |
| Doxiciclina [Italian] |
| Doxigalumicina |
| Doxitard |
| Doxivetin |
| Doxteric |
| DOXY |
| Doxy 100 |
| DOXY 200 |
| Doxy-Caps |
| Doxy-II |
| Doxy-Lemmon |
| Doxy-Puren |
| Doxy-tablinen |
| Doxy-Tabs |
| Doxycen |
| Doxychel |
| Doxychel (TN) |
| Doxychel Hyclate |
| Doxycin |
| Doxycyclin |
| doxycycline |
| Doxycycline (200mg/day) or Placebo |
| Doxycycline (anhydrous) |
| Doxycycline (hydrochloride) |
| Doxycycline (INN) |
| Doxycycline (internal use) |
| Doxycycline (TN) |
| Doxycycline [USAN:INN:BAN] |
| Doxycycline anhydrous |
| DOXYCYCLINE CALCIUM |
| Doxycycline HCl |
| Doxycycline Hyclate (100 mg) |
| Doxycycline hyclate (internal use) |
| Doxycycline hyclate (USP) |
| Doxycycline hyclate [USAN:USP] |
| doxycycline hyclate 20 mg twice daily |
| Doxycycline hydrochloride |
| Doxycycline Hydrochloride [JAN] |
| Doxycycline hydrochloride hemiethanolate hemihydrate |
| Doxycycline hydrochloride hydrate (JP17) |
| DOXYCYCLINE HYLATE |
| Doxycycline-Chinoin |
| Doxycycline, Antibiotic for Culture Media Use Only |
| Doxycycline, Hyclate |
| Doxycycline, hydrochloride, hemiethanolate, hemihydrate; |
| Doxycyclinum |
| Doxycyclinum [INN-Latin] |
| Doxylin |
| Doxyprex |
| Doxysol |
| Doxytec |
| Doxytetracycline |
| DSSTox_CID_25405 |
| DSSTox_GSID_45405 |
| DSSTox_RID_80856 |
| DTXSID0037653 |
| DTXSID1045405 |
| DTXSID4041020 |
| Ecodox |
| EINECS 209-271-1 |
| EINECS 234-198-7 |
| Ethanol, compd. with (4S,4aR,5S,5aR,6R,12aS)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,5,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide monohydrochloride (1:2), monohydrate |
| EU-0100405 |
| FT-0603476 |
| GS-3065 |
| GS-3065 (*monohydrate) |
| GTPL6464 |
| HMS1920I20 |
| HMS2090E06 |
| HSDB 3071 |
| HY-N0565A |
| Hydramycin |
| I015 |
| I455 |
| IDI1_000345 |
| Idocyklin |
| Investin |
| J-000264 |
| J10246 |
| JBIWCJUYHHGXTC-AKNGSSGZSA-N |
| Jenacyclin |
| JRNIHERUNQWMMW-WBYAVNBMSA-N |
| KBio1_000345 |
| KBio2_001287 |
| KBio2_003855 |
| KBio2_006423 |
| KBio3_001156 |
| KBioGR_001133 |
| KBioSS_001287 |
| KS-5254 |
| Liomycin |
| Liviatin |
| LMPK07000001 |
| Lopac0_000405 |
| LP00405 |
| LS-174052 |
| LS-187766 |
| LS-93868 |
| MCULE-4368118692 |
| MCULE-8555113623 |
| Mespafin |
| MFCD07357237 |
| Midoxin |
| MMV000011 |
| MolPort-002-507-423 |
| MolPort-003-666-171 |
| MolPort-005-932-536 |
| MolPort-023-220-303 |
| MolPort-039-338-208 |
| MolPort-042-652-606 |
| Monodoks |
| Monodox |
| Monodox (*monohydrate) |
| NCGC00016693-01 |
| NCGC00161602-01 |
| NCGC00161602-03 |
| NCGC00161602-04 |
| NCGC00161602-05 |
| NCGC00161602-06 |
| NCGC00188979-01 |
| NCGC00261090-01 |
| NINDS_000345 |
| Nivocilin |
| Novadox |
| Novo-Doxylin |
| NPV78C39GQ |
| NSC-633557 |
| NSC-741421 |
| NSC-756751 |
| NSC633557 |
| NSC741421 |
| NSC756751 |
| Nu-Doxycycline |
| Oracea |
| Oxytetracycline, 6-deoxy- |
| Periostat |
| Periostat (TN) |
| Pharmakon1600-01500266 |
| PL000396 |
| PL040705 |
| RETENS |
| Ronaxan |
| Roximycin |
| RPRXAHFLWOCXQL-AKNGSSGZSA-N |
| RUYHIJHUVHIMIR-CVHRZJFOSA-N |
| Samecin |
| SBI-0050391.P004 |
| SC-15766 |
| SCHEMBL17826665 |
| SCHEMBL19270298 |
| SCHEMBL40834 |
| SCHEMBL40930 |
| SCHEMBL66828 |
| SGKRLCUYIXIAHR-AKNGSSGZSA-N |
| SMP1_000107 |
| Spanor |
| SPBio_000246 |
| Spectrum_000807 |
| SPECTRUM1500266 |
| Spectrum2_000143 |
| Spectrum3_000408 |
| Spectrum4_000527 |
| Spectrum5_000947 |
| SR-01000075844 |
| SR-01000075844-7 |
| STOCK1N-34341 |
| Supracyclin |
| Tanamicin |
| Tecacin |
| Tetraclean |
| Tetradox |
| Tox21_110566 |
| Tox21_110566_1 |
| Tox21_500405 |
| UNII-19XTS3T51U |
| UNII-334895S862 |
| UNII-4182Z6T2ET |
| UNII-NPV78C39GQ |
| UPCMLD-DP021 |
| UPCMLD-DP021:001 |
| Vibra-tabs |
| Vibra-tabs (TN) |
| Vibradox |
| Vibramycin |
| Vibramycin (*monohydrate) |
| Vibramycin (TN) |
| Vibramycin hyclate |
| Vibramycin hydrochloride |
| Vibramycin Novum |
| Vibramycin, Hyclate |
| Vibramycine |
| Vibravenos |
| Vivox |
| Vivox (*Hyclate) |
| W-105517 |
| WC 2031 |
| Z2791720087 |
| Zenavod |
| ZINC100056779 |
| ZINC100302137 |
| ZINC100611210 |
| ZINC109562088 |
| ZINC16052277 |
US Patents and Regulatory Information for DOXYCYCLINE HYCLATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Halsey | DOXYCYCLINE HYCLATE | doxycycline hyclate | CAPSULE;ORAL | 062119-002 | May 24, 1985 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Warner Chilcott | DOXYCYCLINE HYCLATE | doxycycline hyclate | TABLET;ORAL | 062593-001 | Aug 28, 1985 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Fresenius Kabi Usa | DOXY 100 | doxycycline hyclate | INJECTABLE;INJECTION | 062475-001 | Dec 9, 1983 | AP | RX | No | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Lupin Ltd | DOXYCYCLINE HYCLATE | doxycycline hyclate | TABLET;ORAL | 208818-002 | Sep 27, 2017 | AB | RX | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for DOXYCYCLINE HYCLATE
| Country | Document Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2006045152 | ➤ Try a Free Trial |
| Australia | 2005299253 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Follow DrugPatentWatch: